Get started
TTE Weekly: Gap Breakout Above Kumo + 200MAOn the weekly chart, TTE is showing a clear polarity shift: Bullish breakout on the weekly timeframe, supported by a gap-up move this week. Price is now back above the Ichimoku Kumo (cloud) → typically a sign of a regime change from bearish/neutral to bullish when sustained. The stock has also reclaimed the 200-day moving average, reinforcing the idea that medium/long-term bias is turning upward. What I’m watching next Confirmation: a weekly close holding above the Kumo + 200MA zone (roughly the €56–57 area on this chart) would strengthen the bullish case. Resistance / upside areas to monitor: the prior supply zone around 60–62, then 64–66 if momentum continues. Invalidation: a weekly close back into the cloud / below the reclaimed averages would weaken the polarity-flip thesis. Catalyst This technical shift could be validated (or rejected) by the next earnings release on Feb 11. I’m treating that event as the key “confirmation trigger” for follow-through.
EURONEXT:TTELong
by mickael_coudert_87
2
Rise of AFME (French)Quick look at Affluent Medical (AFME.PA) on the weekly chart: after years of brutal downtrend from IPO we finally have the first real signs of a technical reversal heading into 2026. Key Technicals (Ichimoku 9-26-52):Current price ~€1.855 (recent close +0.27%, with some intraday strength) Breakout above the Kumo (light green cloud: Span A ~1.743 > Span B ~1.695) Bullish crossover : Tenkan-sen (1.780) > Kijun-sen (1.705) Chikou Span free above past prices → confirmed bullish momentum Major support: €1.695-1.705 (cloud base + historical low zone) Resistances : €1.90-2.00 (first hurdle), then €2.20-2.45 (2025 highs), mid-term target €2.50-3.00+ if volume picks up The cloud is thin and rising ahead → bullish window open as long as we hold above ~€1.74.Fundamental Driver (the big one):Dec 2025 bombshell: Acquisition of Caranx Medical + Artedrone → creation of Carvolix (mini-robotic cardiovascular platform powered by AI) TAVIPILOT (AI-guided TAVI software): FDA clearance July 2025, first commercial US rollout expected early 2026! Massive addressable market: TAVI, stroke thrombectomy, mitral valve (~€23B+ potential) EGM on Jan 30, 2026 to approve deals + financing (Truffle Capital + Edwards Lifesciences up to €30M) Analyst consensus : Average PT ~€3.27-3.72 (highs up to €3.80-4.83) → +70-100%+ upside from here Classic small-cap medtech risks: dilution, cash burn, clinical delays... but the newsflow since late 2025 has been extremely positive (Artus pivotal phase green light, Epygon TCT data, etc.).6-Month Scenario:Bull case: €2.20 → €2.80+ if milestones hit (TAVIPILOT launch, robot implants, strong EGM vote) Bear case : Drop below €1.70 if heavy dilution or small-cap sell-off Personally, this looks like an asymmetric bullish setup: limited downside to cloud support, huge catalyst-driven upside. #AFME #MedTech #Ichimoku #Euronext #SmallCap #AI #Robotics
ALong
by Hibou68
Update on LVMHEURONEXT:MC appeared to be forming a Wave 4 triangle that was expected to resolve higher. However, following macroeconomic news, the stock sold off sharply and found support at a key level that previously acted as major resistance after the October breakout. We view this level as technically significant and attractive. As a result, we have initiated a position equal to 50% of our intended exposure. With earnings scheduled in two days, the upcoming report will be the key catalyst in determining whether the stock can resume its advance and break above the prior €650 high, or whether a deeper correction unfolds. Risk is being actively managed through a predefined stop-loss, and we are awaiting post-earnings confirmation before committing additional capital.
EURONEXT:MCLong
by Vasileios_Kairaktidis
$AM - Dassault shakes off Rafale shoot-down to rise againA snippet from ForexTraderPaul's YT Channel Monday Market Update #211: Greenland is cold whilst Defence Stocks are hot. Dassault share price slide last year after Indian Rafales were shot down as part of the tete-a-tete air battle with Pakistan. That weighed on the share price, however recent orders from Ukraine and others, plus general geo-political sentiment and recent events, have lifted the share price once again. Points to note. - Strong order momentum driven by Rafale exports and European defence re-armament. - Long production timelines provide earnings visibility but limit short-term upside acceleration. - Civil aviation exposure via Falcon jets adds cyclicality alongside defence stability. What traders should be aware of: delivery pacing and export contract timing matter more than demand — delays can temporarily weigh on sentiment.
EURONEXT:AM
by FXTraderPaul
euronext belgium good news good to buybullish divergence with good news good to buy Walvis Bay, Namibia – Cleanergy Solutions Namibia proudly marked the official grand opening of its green hydrogen production and refuelling facility by Right Honourable Dr. Tjitunga Elijah Ngurare, Prime Minister of the Republic of Namibia on behalf of Her Excellency the President Dr. Netumbo Nandi-Ndaitwah. The event brought together national leaders, European dignitaries, industry stakeholders and the local community to mark a major milestone in Namibia’s clean energy journey and its growing role as a logistics and energy hub for Africa. Powering Namibia with locally produced green hydrogen The site features a solar-powered, off-grid electrolyser that produces green hydrogen, a refuelling station for hydrogen-powered vehicles and industrial applications, and a Hydrogen Academy to train Namibians in hydrogen technologies. The locally produced green hydrogen is already being applied for road transport (dual fuel trucks), off road applications (dual fuel tractor) and off grid power generation (monofuel hydrogen genset).
EURONEXT:CMBTLong
by zrrsys
Galp strengthens its Iberian strategy with MoeveIon Jauregui - Analyst at ActivTrades Galp Energia has taken a significant strategic step by reaching a non-binding agreement with Moeve to integrate their downstream businesses in the Iberian Peninsula. The transaction, which aims to create two platforms with European scale —IndustrialCo and RetailCo— seeks to strengthen competitiveness against major players such as Repsol and to accelerate the energy transition using existing assets. The transaction: size, scale, and strategic focus The alliance envisages the merger of both companies’ service station networks, creating a pan-Iberian network of approximately 3,500 points of sale across Spain and Portugal. Under this structure, Galp’s service stations in Spain would largely transition to the Moeve brand, while those in Portugal would operate under the Galp brand, with Ballenoil remaining as a third brand. On the industrial side, Galp would contribute its key asset, the Sines refinery, one of the most competitive complexes in Southern Europe, currently undergoing a transition toward a lower-carbon profile. Notable projects include advanced biofuels (HVO/SAF) and a 100 MW green hydrogen electrolyser, aligned with decarbonisation and energy security objectives. Galp would retain more than 20% of IndustrialCo and shared control of RetailCo, while continuing to be listed on the Portuguese stock exchange. This structure allows Galp to preserve strategic assets outside the scope of the integration, such as upstream and renewables. Fundamental analysis of Galp From a fundamental perspective, the transaction is positive for Galp for several reasons. First, it allows the company to unlock value from mature industrial assets, reduce operational risks, and gain scale in retail without assuming full control. Second, it strengthens Galp’s positioning in electric mobility, convenience solutions, and end customers —segments with higher margins and recurring revenues. In addition, the alliance improves the visibility of future cash flows, supports capital discipline, and reinforces Galp’s defensive profile in an environment of gradual energy transition. Technical analysis of Galp From a technical standpoint, the long-term structure remains broadly range-bound. In the short term, the company experienced sharp corrections in December last year, causing the 50- and 100-day moving averages to fall below the 200-day moving average. More recent news has driven a recovery from the lows around EUR 13.960 to the current price near EUR 15.455. The current Point of Control (POC) is located around EUR 15.843. The stock is currently supported by the 50-day moving average, while the most relevant resistance lies first at the long-term average zone and subsequently at the highs reached last November at EUR 18.505. If the recovery trend is maintained, the price could target these highs and act as a catalyst for a new bullish leg. Conversely, failure to decisively break above the long-term average could be interpreted negatively by the market. The RSI indicator is currently in neutral territory after having recently touched lows. The MACD also points to a recovery process, with a positive histogram but signal lines still below it, indicating some underlying weakness and buying interest concentrated around the current support level. The market interprets the transaction as structurally positive, although not without regulatory and execution risks between both companies, which has at least allowed the stock to embark on an apparent recovery path. Additionally, the ActivTrades Europe Market Pulse indicator signals an increase in RISK-ON sentiment, which could lead to partial profit-taking in stocks with stronger recent performance. Moeve strengthens Galp Portugal The potential integration with Moeve reinforces Galp’s strategic narrative: scale, specialisation, and a pragmatic energy transition. In the medium term, the transaction could act as an additional catalyst for the stock, provided that definitive terms are finalised and financial discipline is maintained. ******************************************************************************************* The information provided does not constitute investment research. The material has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and such should be considered a marketing communication. All information has been prepared by ActivTrades ("AT"). The information does not contain a record of AT's prices, or an offer of or solicitation for a transaction in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. Any material provided does not have regard to the specific investment objective and financial situation of any person who may receive it. Past performance and forecasting are not a synonym of a reliable indicator of future performance. AT provides an execution-only service. Consequently, any person acting on the information provided does so at their own risk. Political risk is unpredictable. Central bank actions can vary. Platform tools do not guarantee success.
EURONEXT:GALPLong
by ActivTrades
Ubisoft Long term entry Ubisoft have had some extremely tough years, facing not only strong financial pressure but also strong backlash from its players. We are however, in very deep territory, and i believe a strong bounce is likely to occur in 2026. It's a semi risky play still, but i believe there are good odds for a comeback within their franchises, it's just a matter of time. It's possible we head to top of the range on a long term timeframe, but a solid bounce is highly likely in my book, $15-25 would seem fair and reasonable, but it's anyones guess. EURONEXT:UBI
EURONEXT:UBILong
by RuinedNarrative
1st HL after MSR Bullish div on Daily IMCD #000191st HL after bullish missing right shoulder divergence on daily, also bullish div on weekly which acknowledges a possible upmove which can be seen on the daily. V2 trigger on daily as well, forming the low. Up after 1st HL, expectation is first target on 2 ATR when 1st higher high forms , then I take 33% out, remainder remains to be seen, I expect to exit another 33% on 3 ATR and remainder on 1 ATR 1W. 1st TP: 80,89 2st TP: 82,99 3st TP: 92,48 E: 77,36 SL: 75,48 R/R: 1:1.88 This is trade #00019 Closed 13 trades now. Hitrate 13 out 18 trades = 72.22%
EURONEXT:IMCDLong
by Tornado_Trading
ETL in an accumulation zoneEutelast is down roughly 96% from its all-time high, which strongly suggests that the macro Elliott Wave 5 cycle may be complete. After such a prolonged decline, the stock appears to have formed a bottom and entered an accumulation phase, with price moving sideways and selling pressure largely exhausted. From a strategic perspective, Eutelsat has the potential to become increasingly valuable in satellite internet, secure communications, and military intelligence, especially as European defense and digital sovereignty gain priority. Given this setup, I see ETL as a long-term opportunity rather than a short-term trade. My approach is to accumulate shares monthly, averaging into the position and allowing time for the thesis to play out. If execution improves and strategic demand materializes, ETL could offer significant upside over the next 10 years, making it an interesting European growth-and-defense play.
EURONEXT:ETLLong
by Julian007935
BESI Bullish ContinuationAfter a period of movement within this bull flag pattern, BESI looks ready for bullish continuation after retesting the upper trendline of the bull flag. Fundamentally this adds up given the increasing demand in chips used for different technologies including AI. What Besi Does: - Designs & Builds Machines: They create the specialized equipment that semiconductor manufacturers use to build and package chips. - Focuses on Advanced Packaging: Their technology supports traditional leadframe packaging, substrate-based packaging, and cutting-edge wafer-level packaging (like hybrid bonding) for complex chips. - Provides Key Processes: Their equipment handles tasks like die bonding, molding the chip, trimming the leads, and marking the final package. - Serves High-Growth Markets: They are crucial suppliers for consumer electronics, mobile internet devices, automotive systems, and increasingly, AI and high-performance computing. I believe this will be a good stock to hold for 2026.
EURONEXT:BESILong
by Decrazer
Dassault Aviation Société AnonymeFor my last idea of the year I have chosen to write one about Dassault Aviation. I really find aerospace and defense companies to be the most interesting to me in all of the stock market. As a matter of fact the majority of my holdings are invested into aerospace and defense companies. Aeronautics has always been an extremely competitive industry, ever since the first airplanes, engineers constantly strive to make the technology better, faster, safer and more cost effective. I chose Dassault because I think the Rafale fighter program has a competitive advantage over the rest of the competition for the moment. There was also some issues, I remember around March of 2025 I saw on the news about how some nations were concerned with the credibility of the US and some nations even cancelled or suspended contracts with Lockheed Martin to delay F-35 purchases. I don't want to talk about that too much because I don't really know what is going on with that topic of discussion to tell you the truth. I do know nations take their national security very seriously though and aerospace and defense is no exception. Like most aerospace and defense companies right now it is difficult to see very much upside intrinsically speaking. The sector has had some really nice attention and momentum this year, I don't see why it wouldn't continue into 2026 and beyond. I think its important to realize I am not really speculating about the topic though. I am not trying to say "buy it because I think it will go up". I think good ideas are just as important in the stock market as risk management itself and if you ask me I don't think its worth risking very much on Dassault right now. Primary capital allocation is designated to research and development, industrial infrastructure and supply chain management. These are important elements when we look at the price of Dassault on a chart because the capital expenditures are primarily why certain price actions occur in real time. For example, if the company needs money to finance something new, the price of the shares might drop temporarily as money is being spent, alternatively if they get a new contract and its a big deal, they expect to make a lot of money from it the share price might go up. This is why I love these industrial companies, because we all know the products the company is providing is going to need a lot of maintenance over the years. The company actively partakes in employee share programs, Dassault has allocated hundreds of millions of Euros toward employee incentives and profit-sharing in the current fiscal cycle. The company also likes to reward shareholders by engaging in share buy back programs from time to time. There is also a slight dividend that the company pays out as well if that is something you receive then you will know it helps out the portfolio a little bit. The company has a pretty large cash position valued at about €10 billion at the end of 2025. This is primarily from advanced payments received by nations for major Rafale export contracts. Currently there is a record breaking order backlog on aircraft orders going into 2026, there is about €48 billion in backlog value. Don't quote me on this though because that was the value about 6 months ago so today it could be a little more or less, the value doesn't really matter to us as retail investors but I am just saying it for context. The company plans to take care of this backlog in a timely manner though, they plan to invest in more industrial capacity. Recently the company celebrated production of its 300th Rafale fighter jet, and announced plans to increase production rates to four aircraft per month in the coming years to ensure deliveries stretch reliably into the 2030s. I think the stock would make a fine addition to any properly diversified portfolio as long as you understand the potential risks associated. Its a pretty interesting company I think there's definitely some great information on the internet and I am happy that I got to write this idea and share some information today. Merry Christmas and thanks for putting up with me. Hope you enjoyed the idea.
EURONEXT:AMLong
by Capitalist_Zach
2
LVMH Bullish!!!There are several bullish factors for EURONEXT:MC , with three possible scenarios, each depending on which support level holds. Scenario 1 Price is moving within the yellow rising channel, forming a bull flag and a healthy pullback after the recent rally. The expectation is a move toward the confluence support (orange circle) before resuming the uptrend. Scenario 2 Price is respecting the ascending blue channel, which represents a healthy bullish trend. A bounce from the blue support line would provide buying confirmation. Scenario 3 After a bullish advance, price has formed a triangle, which statistically favors continuation. The structure appears to be completing an ABCD move, with a final E leg likely toward the blue support. From there, price could break upward out of the triangle and move toward the blue-arrow target, assuming the yellow and blue resistance levels do not cap the advance.
EURONEXT:MCLong
by Vasileios_Kairaktidis
10
FDJ: A Technically Strong and Fundamentally Solid SupportFDJ (Française des Jeux) shares are currently approaching a historical zone of major technical support, located between €18 and €22. The stock has not yet entered this strong support zone, but it deserves close monitoring, as there are solid fundamental arguments that give this level credibility and make it likely that this support zone could generate a bullish reaction in the stock. While technical analysis highlights a price area that has historically been defended, the key question for investors remains the following: is this level purely technical, or is it also fundamentally justified? The answer requires nuance, but several elements clearly argue in favor of an economically “defendable” support for FDJ shares. The first pillar of the FDJ investment thesis remains its legal monopoly in France. The company benefits from an exclusive concession covering lotteries, scratch cards, and sports betting in physical points of sale, secured until 2044. This situation provides rare visibility on future revenue streams and creates nearly insurmountable barriers to entry. Very few listed companies enjoy such a high degree of regulatory protection, which historically explains the valuation premium granted to the stock. In addition to this visibility, FDJ demonstrates a particularly robust cash generation capacity. The company posts high margins, limited capital expenditure requirements, and structurally positive free cash flow. Even in a more challenging macroeconomic environment, the business model has proven resilient. This cash-flow quality is a key argument for long-term investors when the stock revisits historically low price levels. Dividend policy also plays a stabilizing role. Distributions are regular, sustainable, and supported by a low-cyclicality business model. Following the share price correction, the dividend yield becomes attractive again, which tends to reinforce interest from income-oriented funds and to create a psychological floor around the current support area. This does not guarantee an immediate rebound, but it limits the risk of prolonged investor disengagement at these levels. Furthermore, the gradual digitalization of the business provides a measured but profitable growth driver. FDJ has so far managed to develop its digital channels without destabilizing its physical network, while improving margin mix and customer insight. This evolution helps modernize the business model without significantly increasing its risk profile. However, caution remains warranted. Regulatory pressure, sector-specific taxation, and structurally moderate growth justify the fact that the stock may not automatically return to its previous highs. Nonetheless, a reaction around this strong technical support zone between €18 and €22 appears plausible. The current support is therefore not a certainty of trend reversal, but rather a zone where the risk-reward profile becomes attractive again from both a technical and fundamental standpoint. DISCLAIMER: This content is intended for individuals who are familiar with financial markets and instruments and is for information purposes only. The presented idea (including market commentary, market data and observations) is not a work product of any research department of Swissquote or its affiliates. This material is intended to highlight market action and does not constitute investment, legal or tax advice. If you are a retail investor or lack experience in trading complex financial products, it is advisable to seek professional advice from licensed advisor before making any financial decisions. This content is not intended to manipulate the market or encourage any specific financial behavior. Swissquote makes no representation or warranty as to the quality, completeness, accuracy, comprehensiveness or non-infringement of such content. The views expressed are those of the consultant and are provided for educational purposes only. Any information provided relating to a product or market should not be construed as recommending an investment strategy or transaction. Past performance is not a guarantee of future results. Swissquote and its employees and representatives shall in no event be held liable for any damages or losses arising directly or indirectly from decisions made on the basis of this content. The use of any third-party brands or trademarks is for information only and does not imply endorsement by Swissquote, or that the trademark owner has authorised Swissquote to promote its products or services. Swissquote is the marketing brand for the activities of Swissquote Bank Ltd (Switzerland) regulated by FINMA, Swissquote Capital Markets Limited regulated by CySEC (Cyprus), Swissquote Bank Europe SA (Luxembourg) regulated by the CSSF, Swissquote Ltd (UK) regulated by the FCA, Swissquote Financial Services (Malta) Ltd regulated by the Malta Financial Services Authority, Swissquote MEA Ltd. (UAE) regulated by the Dubai Financial Services Authority, Swissquote Pte Ltd (Singapore) regulated by the Monetary Authority of Singapore, Swissquote Asia Limited (Hong Kong) licensed by the Hong Kong Securities and Futures Commission (SFC) and Swissquote South Africa (Pty) Ltd supervised by the FSCA. Products and services of Swissquote are only intended for those permitted to receive them under local law. All investments carry a degree of risk. The risk of loss in trading or holding financial instruments can be substantial. The value of financial instruments, including but not limited to stocks, bonds, cryptocurrencies, and other assets, can fluctuate both upwards and downwards. There is a significant risk of financial loss when buying, selling, holding, staking, or investing in these instruments. SQBE makes no recommendations regarding any specific investment, transaction, or the use of any particular investment strategy. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The vast majority of retail client accounts suffer capital losses when trading in CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Digital Assets are unregulated in most countries and consumer protection rules may not apply. As highly volatile speculative investments, Digital Assets are not suitable for investors without a high-risk tolerance. Make sure you understand each Digital Asset before you trade. Cryptocurrencies are not considered legal tender in some jurisdictions and are subject to regulatory uncertainties. The use of Internet-based systems can involve high risks, including, but not limited to, fraud, cyber-attacks, network and communication failures, as well as identity theft and phishing attacks related to crypto-assets.
EURONEXT:FDJU
by Swissquote
GENFIT, a Technical Accumulation Base?For nearly five years, Genfit’s share price has been moving within a broad consolidation zone between €3 and €6, forming a horizontal accumulation base on the long-term timeframe represented here by monthly candlesticks. This type of pattern, especially visible on a logarithmic chart, often appears after a long downtrend and can form the foundation for a sustainable bullish reversal if and only if prices eventually break out to the upside. According to technical analysis principles, repeated rebounds at €3 and the gradual reduction in volatility are encouraging signs. But a credible bullish breakout requires a clear technical breakout above the upper boundary of the range, and, importantly, tangible fundamental catalysts to confirm any potential technical signal. On the fundamental side, Genfit is now in a stronger position than a few years ago. The company has reached a major milestone with the market launch of Iqirvo® (elafibranor) for primary biliary cholangitis (PBC), in partnership with Ipsen. This entry into direct commercial activity marks a strategic shift: the biotech is now generating recurring revenues through royalties and milestone payments, which already produced €67M of revenue in 2024 and a growing first quarter of 2025. This momentum provides a potential engine for renewed market confidence. Furthermore, Genfit has a solid cash position, reinforced by up to €185M in non-dilutive financing. This financial visibility through 2027–2028 limits dilution risk and supports a diversified commercial pipeline. Expanding elafibranor’s indications or positive clinical results could act as major catalysts and justify a bullish breakout from the current base. However, several elements call for caution. Despite its pipeline, Genfit remains heavily dependent on a single already commercialized product. If Iqirvo’s sales grow more slowly than expected, or if competition intensifies, the upside could remain limited. The biotech sector also remains intrinsically volatile: program discontinuations, regulatory uncertainties or disappointing clinical results could prolong the current lateral phase between €3 and €6. The market appears to be waiting for more concrete evidence before sustainably revaluing the company, and at this stage, technical analysis has not produced a bullish breakout signal. In summary, the technical base is real and could serve as a springboard for a bullish reversal. But this scenario will depend primarily on Genfit’s ability to confirm its commercial ramp-up and translate its pipeline into clinical and economic value. Until these signals are validated, the sideways trading between €3 and €6 may continue. DISCLAIMER: This content is intended for individuals who are familiar with financial markets and instruments and is for information purposes only. The presented idea (including market commentary, market data and observations) is not a work product of any research department of Swissquote or its affiliates. This material is intended to highlight market action and does not constitute investment, legal or tax advice. If you are a retail investor or lack experience in trading complex financial products, it is advisable to seek professional advice from licensed advisor before making any financial decisions. This content is not intended to manipulate the market or encourage any specific financial behavior. Swissquote makes no representation or warranty as to the quality, completeness, accuracy, comprehensiveness or non-infringement of such content. The views expressed are those of the consultant and are provided for educational purposes only. Any information provided relating to a product or market should not be construed as recommending an investment strategy or transaction. Past performance is not a guarantee of future results. Swissquote and its employees and representatives shall in no event be held liable for any damages or losses arising directly or indirectly from decisions made on the basis of this content. The use of any third-party brands or trademarks is for information only and does not imply endorsement by Swissquote, or that the trademark owner has authorised Swissquote to promote its products or services. Swissquote is the marketing brand for the activities of Swissquote Bank Ltd (Switzerland) regulated by FINMA, Swissquote Capital Markets Limited regulated by CySEC (Cyprus), Swissquote Bank Europe SA (Luxembourg) regulated by the CSSF, Swissquote Ltd (UK) regulated by the FCA, Swissquote Financial Services (Malta) Ltd regulated by the Malta Financial Services Authority, Swissquote MEA Ltd. (UAE) regulated by the Dubai Financial Services Authority, Swissquote Pte Ltd (Singapore) regulated by the Monetary Authority of Singapore, Swissquote Asia Limited (Hong Kong) licensed by the Hong Kong Securities and Futures Commission (SFC) and Swissquote South Africa (Pty) Ltd supervised by the FSCA. Products and services of Swissquote are only intended for those permitted to receive them under local law. All investments carry a degree of risk. The risk of loss in trading or holding financial instruments can be substantial. The value of financial instruments, including but not limited to stocks, bonds, cryptocurrencies, and other assets, can fluctuate both upwards and downwards. There is a significant risk of financial loss when buying, selling, holding, staking, or investing in these instruments. SQBE makes no recommendations regarding any specific investment, transaction, or the use of any particular investment strategy. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The vast majority of retail client accounts suffer capital losses when trading in CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Digital Assets are unregulated in most countries and consumer protection rules may not apply. As highly volatile speculative investments, Digital Assets are not suitable for investors without a high-risk tolerance. Make sure you understand each Digital Asset before you trade. Cryptocurrencies are not considered legal tender in some jurisdictions and are subject to regulatory uncertainties. The use of Internet-based systems can involve high risks, including, but not limited to, fraud, cyber-attacks, network and communication failures, as well as identity theft and phishing attacks related to crypto-assets.
EURONEXT:GNFT
by Swissquote
Thales SA (HO) Thales, Rheinmetall and others European Defense stocks would likely drop in the short term (peace Russia-Ucraina) due to the immediate market reaction to reduced conflict. The long-term outlook would be more complex. A lasting peace could slow the growth from the immediate "war economy" demands, but it is unlikely to reverse the broader European defense industry trend of increased long-term spending on rearmament and defense modernization, driven by structural shifts and increased security concerns in Europe. It will be necessary to evaluate the "quantity" of soldiers actually available to "maneuver" all the means. Demographics is a huge force.
EURONEXT:HOShort
by mgiuliani
1
AIR moves below 200 Euro and the 20MA - a sign of more to come?We saw AIR down by 10% in early trading today. A mix of the recall note on 600 A320 airliners for the effect solar radiation has been found to have on the flight software, and a possible Ukraine Peace plan knocking all European defence stocks. The former is quite some issue - but, by my superficial understanding, is a software fix, and relatively easy to complete (please correct me if I'm wrong). However the possibility of a Ukraine Peace Plan will have a bigger impact on European Defence and Aerospace stock, and that is what will concern investors. Just looking at the technical chart we see that AIR had a great bullish trend (like most other aerospace and defence stocks) but over the last few weeks that has peaked, and in AIRs case seen an acceleration of lower prices, which the A320 issue has accelerated. We are now beneath the 200 Euro level and have pushed beneath the weekly 20 MA. Now of course we are only on day 1 of this weeks candle so things will change. however if price finishes this week beneath 200 Euros and the 20MA, and the Ukraine Peace Plan gains traction then a bearish sentiment on AIR and other similar companies would be valid.
EURONEXT:AIRShort
by FXTraderPaul
2